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PURPOSE. Scleral stiffening has been proposed as a treatment for glaucoma to protect the
lamina cribrosa (LC) from excessive intraocular pressure–induced deformation. Here we
experimentally evaluated the effects of moderate stiffening of the peripapillary sclera on the
deformation of the LC.
METHODS. An annular sponge, saturated with 1.25% glutaraldehyde, was applied to the
external surface of the peripapillary sclera for 5 minutes to stiffen the sclera. Tissue
deformation was quantified in two groups of porcine eyes, using digital image correlation
(DIC) or computed tomography imaging and digital volume correlation (DVC). In group A (n
¼ 14), eyes were subjected to inflation testing before and after scleral stiffening. Digital image
correlation was used to measure scleral deformation and quantify the magnitude of scleral
stiffening. In group B (n ¼ 5), the optic nerve head region was imaged using synchrotron
radiation phase-contrast microcomputed tomography (PC lCT) at an isotropic spatial
resolution of 3.2 lm. Digital volume correlation was used to compute the full-field three-
dimensional deformation within the LC and evaluate the effects of peripapillary scleral cross-
linking on LC biomechanics.
RESULTS. On average, scleral treatment with glutaraldehyde caused a 34 6 14% stiffening of
the peripapillary sclera measured at 17 mm Hg and a 47 6 12% decrease in the maximum
tensile strain in the LC measured at 15 mm Hg. The reduction in LC strains was not due to
cross-linking of the LC.
CONCLUSIONS. Peripapillary scleral stiffening is effective at reducing the magnitude of
biomechanical strains within the LC. Its potential and future utilization in glaucoma axonal
neuroprotection requires further investigation.
Keywords: biomechanics, phase contrast microcomputed tomography, digital image
correlation, digital volume correlation
Glaucoma, the second leading cause of irreversible blind-ness, affects over 60 million people worldwide.1 Intraoc-
ular pressure (IOP) plays an important role in the
pathophysiology of glaucoma: Elevated IOP is a risk factor for
the disease, and significant, sustained IOP reduction benefits
most patients.2,3 All treatments for glaucoma in present clinical
use attempt to modulate aqueous humor fluid dynamics to
reduce IOP. Unfortunately, loss of vision progresses in 25% to
45% of patients2,4 despite reduction of IOP. Therefore, there is a
critical need to develop new treatments for glaucoma not based
upon the paradigm of lowering IOP.
Vision loss in glaucoma is caused by the slow and
irreversible loss of retinal ganglion cell axons. Evidence
suggests that biomechanical factors acting on the axons, cells,
and extracellular matrix of the optic nerve head (ONH)
contribute to this process.5,6 Damage to the axons first occurs
in the lamina cribrosa (LC),7 which undergoes substantial
deformation,8 and ONH astrocytes are known to alter their
phenotypic expression when subjected to mechanical in-
sults.9,10 These data suggest that reducing the deformation
experienced by ONH tissues may be beneficial for glaucoma
patients.11–13
Computer modeling work has shown that a major factor
controlling the deformation of the LC is the stiffness of the
sclera,14,15 especially the stiffness of the peripapillary sclera.16
These studies predicted that the LCs of eyes with stiffer scleras
would deform less. Accordingly, altering the biomechanical
properties of the sclera has been suggested as a potential
approach to protect individuals with elevated IOP or with
comparatively less stiff scleras from glaucomatous inju-
ry.6,11–13 However, it is unclear as to whether a stiffer sclera
is in fact neuroprotective. On one hand, eyes from mice with
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experimental glaucoma that experienced greater scleral
strains were more prone to axonal damage.17 Further, animal
studies have suggested that natural stiffening of the sclera may
occur in early glaucoma as a protective response to shield the
ONH from the mechanical insult caused by long-term
exposure to IOP. For example, increased scleral stiffness
was observed in a mouse model of experimental glaucoma
using an inflation test17 and in a monkey model of
experimental glaucoma using uniaxial relaxation18 and
inflation testing.19 A stiffer sclera has also been reported in
humans with glaucoma20,21; however, nonlongitudinal human
studies cannot determine if these patients had increased
scleral stiffness prior to glaucoma or if it was a response to
the disease. On the other hand, mice with experimentally
induced glaucoma whose scleras were chemically stiffened
exhibited more axon loss compared to experimental glauco-
ma mice whose scleras were left unstiffened.22 Further
research is needed to elucidate the neuroprotective effects,
if any, of increased scleral stiffness in glaucoma. An essential
part of this research is the quantification of how altering
scleral stiffness impacts LC deformation.
Stiffening collagen-rich tissues such as the sclera or the
cornea can be achieved by treatment with cross-linking
agents. For instance, physical corneal collagen cross-linking
via ultraviolet (UV)-activated riboflavin treatment is now
commonly used to prevent the progression of keratoconus,23
and scleral cross-linking with riboflavin is currently being
tested in animal models as a treatment for myopia.24
Treatment of the sclera with riboflavin/UV or chemical agents
such as glutaraldehyde or glyceraldehyde resulted in in-
creased scleral stiffness as measured with uniaxial tensile
testing.25 A recent study by Thornton et al.26 showed that
treatment of the peripapillary sclera with glutaraldehyde
caused a 3-fold increase in scleral stiffness and a large
decrease in LC tensile deformation. However, the authors
used relatively low-resolution tools to measure the mechan-
ical behavior of the sclera and the LC, and more experimental
studies are needed to assess the effects of scleral stiffening on
LC deformation. Here, we have quantified the effects of
peripapillary scleral stiffening on the three-dimensional (3D)
deformation of the LC using high-resolution imaging and
deformation mapping techniques.
MATERIALS AND METHODS
Overall Approach
The overall goal of this study was to estimate the effects of
glutaraldehyde-induced peripapillary scleral stiffening on the
deformation, or ‘‘strain’’ of the LC. Although we do not
propose glutaraldehyde as a viable in vivo stiffening agent due
to biocompatibility limitations, it was suitable for use in this
proof-of-principle study as it is known to produce significant
stiffening of collagenous tissues in short time frames.26 After
verifying that glutaraldehyde delivery was localized to the
sclera and did not diffuse into the LC, we quantified the relative
scleral stiffening caused by a superficial application of a 1.25%
glutaraldehyde solution to the peripapillary sclera. Scleral
specimens were subjected to inflation testing before and after
glutaraldehyde treatment, and peripapillary scleral deformation
was measured with digital image correlation (DIC). We refer to
this study as experiment A in the remainder of the paper. Next,
we evaluated the effects of scleral stiffening on deformation
within the LC. The 3D structure of the LC was imaged at
increasing levels of IOP using phase-contrast microcomputed
tomography (PC lCT), and IOP-induced LC strains were
computed with digital volume correlation (DVC). We refer to
this study as experiment B in the remainder of the paper.
Specimen Preparation
Porcine eyes, obtained from local slaughterhouses within 24
hours of death, were divided into two experimental groups.
The first group, consisting of 14 eyes from animals aged 24
months (Holifield Farm, Inc., Farmington, GA, USA), was used
in experiment A, conducted at Georgia Institute of Technology,
Atlanta, Georgia. The second set consisted of five eyes from
animals aged 5 months (Elmkirk, London, UK) and was used in
experiment B, conducted at Diamond Light Source synchro-
tron (Didcot, UK). All eyes were stored in a moist chamber at
48C prior to dissection, which occurred within 72 hours post
mortem, within the time frame over which scleral properties
are known to be preserved.27 Both sets of eyes were prepared
using the protocol described in Coudrillier et al.28 In brief, the
eyes were cleaned of extraorbital fat and muscles, hemisected,
and glued with cyanoacrylate at the corneal/scleral limbus
onto a resin holder (Fig. 1A). The mounted specimens were
FIGURE 1. Scleral stiffening procedure. (A) Schematic representation of the treatment region in the peripapillary sclera. This is a side view of the
specimen, glued on the holder at the limbus, with the optic nerve facing up. Note that the length of the optic nerve is exaggerated in this schematic.
Only 1 mm of optic nerve was left in the experiments. The approximate treatment zone is shaded in black and the sponge is represented in gray.
The sponge was not pressed onto the scleral surface. (B) Top view of the specimen during treatment, with the annular sponge placed on the
peripapillary sclera around the ONH, which is visible in the center. Scleral stiffening was performed when the specimen was mounted on the
pressure chamber. The annular sponge was immersed in the 1.25% (vol/vol) glutaraldehyde solution and placed around the optic nerve for 5
minutes. (C) Delineation of the treatment region after treatment, as viewed by a camera looking down on the specimen. The cross-linking solution
was yellow (not visible in this black and white picture), which allowed us to trace the contours of the treatment zone.
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then secured onto a pressure chamber (Fig. 2) filled with
isotonic phosphate-buffered saline (PBS). Intraocular pressure
could be hydrostatically adjusted by controlling the vertical
position of a PBS-filled reservoir. The mounted eye was then
immersed in a PBS bath to maintain constant hydration and
environmental temperature during testing. Eyes were inflated
to 15 mm Hg for 20 minutes to ensure the absence of leaks at
the glued interface between the hemisected eye and the holder
before starting the scleral or LC deformation measurements.
No further preconditioning tests were performed on the
specimens.28,29
Scleral Cross-Linking
Peripapillary Scleral Treatment. Scleral cross-linking
was achieved by topical application of a 1.25% (vol/vol)
solution of glutaraldehyde (dilution of a 25% biological-grade
solution [Electron Microscopy Science, Hatfield, PA, USA] in
PBS) fluorescently labeled by addition of fluorescein sodium
salt (Sigma-Aldrich Corp., St. Louis, MO, USA) to reach a final
concentration of 0.33 mM. The cross-linking solution had a
bright yellow color, which allowed us to precisely track the
region of the scleral surface treated with glutaraldehyde and
ensure that no drops of fixative-containing solution ran down
the scleral surface from the sponge. In more detail, an annular
sponge made of synthetic foam was immersed in this
glutaraldehyde solution, blotted on absorbent paper to remove
excess solution that might run down the scleral surface, and
placed on the external surface of the peripapillary sclera for 5
minutes, as shown in Figure 1A.26 After treatment, the scleral
surface was immersed in PBS three times to wash the excess
glutaraldehyde from the surface. We did not rely on the yellow
stain caused by fluorescein to measure lateral diffusion of
glutaraldehyde. This was done in another experiment de-
scribed below.
Validation of the Cross-Linker Application. Glutaralde-
hyde, which has a relatively small molecular weight (100.12
gmol1), is expected to diffuse through the peripapillary sclera
upon application. With enough time, glutaraldehyde could
diffuse into the LC. From the physics of diffusion, we expected
that if glutaraldehyde reached the LC, the concentration of
glutaraldehyde would be larger in the LC regions closest to the
peripapillary sclera (i.e., the periphery of the LC versus the
center of the LC), and the concentration of glutaraldehyde in
the LC would increase with time until reaching an equilibrium
value.
It was important to verify that the LC remained unstiffened
after 5 minutes of scleral exposure to 1.25% glutaraldehyde,
since the point of this study was to evaluate the effects of
scleral stiffening alone on LC deformations. The diffusion
coefficients of glutaraldehyde in the sclera and the LC are
unknown, and the concentration of glutaraldehyde within the
LC after treatment could not be numerically estimated. Thus,
we instead used the autofluorescence of tissue fixed with
glutaraldehyde as a marker to experimentally determine the
maximum concentration of glutaraldehyde, if any, present in
the LC. This was done in the following two steps.
Overnight Incubation of LCs in Glutaraldehyde (Step 1).
In the first step, we determined a ‘‘dose–response’’ curve
between the glutaraldehyde concentration in the LC and tissue
autofluorescence. To do so, we measured the fluorescence of
LCs incubated overnight in solutions with different concentra-
tions of glutaraldehyde, with the expectation that overnight
incubation would be long enough for the concentration of
glutaraldehyde to have reached an equilibrium value across the
LC. Eleven fresh porcine eyes were dissected to isolate the
ONH region. The retina was gently excised but the choroid was
left on the specimen. Each specimen was then incubated
overnight in a different concentration of glutaraldehyde
solution, varying from 1.25% (stock solution) to 0.01%. One
control specimen was incubated in PBS. We did not use
fluorescein in this experiment as fluorescein has a larger
molecular mass and would diffuse more slowly within the
sclera. Following incubation, all excess glutaraldehyde solution
was removed by immersion in PBS for 1 hour. The specimens
were then embedded in Tissue-Tek optimal cutting tempera-
ture medium (OCT; Sakura Finetek, Torrance, CA, USA) and
snap frozen at808C. For each specimen, eighteen 20-lm-thick
cryosections through the LC were cut on a CryoStar NX70
cryostat (Microm International GmbH, Dreieich, Hessen,
Germany), three of which were randomly selected per eye
and imaged using a310 objective lens on a Zeiss LSM 700-405
microscope (Jena, Thuringia, Germany) with 555-nm laser
excitation. The autofluorescence of glutaraldehyde-fixed tissue
is maximally excited at 540 nm, with an emission peak at 560
nm.30 The confocal pinhole was set to 1 AU (12.3 lm), the
laser power set to 2%, the digital offset to 0, and the digital gain
set to 4.
We expected that the autofluorescence of the LC exposed
to glutaraldehyde would depend on the concentration of
glutaraldehyde in the incubation solution. As a measure of
tissue autofluorescence for each concentration, we determined
the maximum detector gain that would saturate a few pixels of
the brightest optical section of each slice (as seen on the
saturation color map, Zeiss, Zen), and plotted this gain versus
glutaraldehyde concentration to obtain a suitable ‘‘gain–
concentration curve.’’
Scleral Treatment With 1.25% Glutaraldehyde Treatment
(Step 2). In the second step, we used the above-determined
curve to estimate the concentration of glutaraldehyde in the LC
caused by peripapillary scleral stiffening. Our specific goal was
to demonstrate that no glutaraldehyde had reached the LC after
FIGURE 2. Schematic representation of the experimental setup used
for digital image correlation. The sclera was securely attached to an
inflation chamber, which was connected to a syringe filled with PBS,
the height of which was manually adjusted to control pressure in the
chamber. Two cameras imaged the deforming sclera during inflation at
a rate of 1 Hz. The inflation chamber was immersed in a PBS bath, not
shown in this figure. Note that a relatively long optic nerve was initially
left on the eye for this photo. It was cut to a length of approximately 1
mm before starting the inflation test to ensure quality correlation in the
DIC measurements of the peripapillary scleral deformation.33
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5 minutes of exposure via the sponge on the peripapillary
scleral surface. The peripapillary scleral surface of seven
different porcine eyes was treated with 1.25% glutaraldehyde
for times varying between 5 minutes and 6 hours following the
protocol shown in Figure 1. For treatment times longer than 1
hour, the annular sponge was soaked in glutaraldehyde hourly
to ensure that the supply of cross-linking solution was not
depleted. After treatment, the ONH region was dissected and
washed for 1 hour in PBS. Transverse cryosections of the LCs
were prepared and imaged following the protocol described in
step 1. In this experiment, diffusion of glutaraldehyde occurs
between the peripapillary sclera and the LC (initial concentra-
tion ¼ 0%). Similarly to the procedure in step 1, we measured
the maximum detector gain that saturated a few pixels of the
peripheral and central LC, and used the curve generated in
step 1 to estimate the evolution of the concentration of
glutaraldehyde in those regions versus treatment time.
Experiment A: Measurement of the Relative Scleral
Stiffening
Digital Image Correlation. Fourteen posterior porcine
scleral shells were subjected to inflation testing to measure
their mechanical behavior in response to elevation of pressure.
The scleral shells were mounted on the inflation chamber
shown in Figure 1. Surface displacement maps of the sclera
were computed using DIC, a technique previously applied to
measure the deformation of bovine31 and human32 sclera. Prior
to testing, the sclera was air brushed with black Indian ink to
create a contrast pattern for deformation tracking. Two
cameras, located approximately 50 cm above the inflation
chamber with a 258 stereo angle, acquired pictures of the
deforming sclera at a rate of 1 Hz (Fig. 2). Test image pairs were
analyzed with a 3D DIC software package (Istra 4D 4.4.1;
Dantec Dynamics, Holtsville, NY, USA) to compute full-field
displacements of the scleral surface (30.7 lm/pixel, facet size¼
51 pixels, overlap ¼ 21 pixels). The DIC software includes a
compensation method to correct for optical distortions due to
change in refraction indices at the surface of the PBS bath.
Displacements were smoothed using cubic splines (grid
reduction factor ¼ 4) before computing the 2D surface
Green-Lagrange strain tensor and principal strains with the
algorithm implemented in Istra 4D. The two principal strains
represent the maximum and minimum stretches of an
elemental scleral surface. The uncertainty in the strain
calculation was estimated by taking two sets of stereo images
of the equilibrated sclera 1 second apart31 without varying IOP
and correlating the second image set with the first to compute
displacements and strains. In this scenario, we expect the
computed strains to be uniformly zero. The strain uncertainty
was defined as the standard deviation of the computed first
principal strain over the entire peripapillary sclera, defined as
the region spanning a radial distance from 1.5 to 6 mm from
the center of the ONH. The uncertainty was estimated to be
0.5 millistrain.
After uncertainty estimation, the specimen (not yet treated
with glutaraldehyde) was allowed to equilibrate for 20 minutes
at 2 mm Hg before beginning the inflation test. The pressure
was increased from 2 to 38.5 mm Hg by steps of 7.3 mm Hg
(i.e., 6 steps of 10 cmH2O) and maintained at each pressure
step for 10 seconds. The pressure was then lowered and held
at the baseline pressure of 2 mm Hg. The inflation chamber
and specimen were taken out of the PBS bath, and the
peripapillary sclera was treated for 5 minutes with 1.25%
glutaraldehyde using the protocol shown in Figure 1. After
three washes of any excess glutaraldehyde with PBS, the PBS
bath was filled with fresh PBS and the inflation test was
repeated on the treated specimen. Note that the treatment and
the washes did not alter the speckling pattern, and that the
same camera calibration and specimen orientation were used
to measure the mechanical behavior of the specimen before
and after treatment.
Scleral Stiffening Quantification. The relative scleral
stiffening at pressure step p was calculated as:
Sp ¼ 1003 e
p
untreated  e ptreated
e puntreated
; ð1Þ
where e puntreated and e
p
treated are the first principal strains (i.e.,
maximum tensile deformation) averaged over the entire
peripapillary sclera at pressure p before and after treatment,
respectively. e puntreated and e
p
treated were computed from the
strain profile obtained in the last stereo images acquired at
pressure step p. The specimen had to be taken out of the PBS
bath for treatment and therefore was not in the exact same
orientation/location before and after treatment. To prevent
error arising from registration of the specimens, we used an
axisymmetric region centered on the optic nerve (ON) for
strain averaging, after manual registration of the center of the
ON between the treated and untreated scans. The peripapillary
sclera was defined as the disc-shaped region lying between 1.5
and 6 mm from the ONH center. Material points with poor
correlation values were not included in the strain average over
this region; however, because we used the same speckling
pattern, these regions were nearly identical for the treated and
untreated specimens, so that treated/untreated comparisons
were valid.
As a control experiment, we recorded two inflation tests 15
minutes apart for six specimens incubated in PBS instead of
glutaraldehyde. We compared the relative stiffening to zero at
each pressure using a 1-sample t-test with a Bonferroni
correction (adjusted P value of 0.01).
Experiment B: IOP-Induced Strain in the LC
Phase-Contrast Microcomputed Tomography. The
effects of IOP on the 3D deformation of the LC were measured
with phase-contrast PC lCT on beamline I12, Joint Engineer-
ing, Environment and Processing at Diamond Light Source.34
The experimental protocol for PC lCT was described in a
previous publication28 and is briefly summarized here. A highly
coherent x-ray beam was directed toward the ONH region of a
hemisected eye mounted on a turntable (Fig. 3). The phase
shift caused by the interaction of the x-rays with the tissues of
the ONH was transformed into intensity variations and
recorded using a charge-coupled device detector with an
effective voxel size of 3.2 lm placed 2 m behind the specimen.
We acquired 3600 projections of the ONH region and used an
exposure time of 5 ms per projection (total scan time at each
pressure ~90 seconds). The reconstructed scans encompassed
a 7-3 7-3 7-mm3 region centered on the LC.35 To reduce the
file size of the image volume used for image processing, the
images were down-sampled by a factor of 2 (Matlab [Math-
works, Natick, MA, USA] command imresize). The effective
voxel size of the down-sampled image volume was 6.4 lm.
Phase-contrast microcomputed tomography scans were re-
corded at three different levels of IOP: 4, 15, and 30 mm Hg.
The specimens were equilibrated at each pressure for 15
minutes before starting the scan to minimize motion caused by
creep, which would manifest as a smearing artifact and ruin
the scan. After acquiring the scan at 30 mm Hg, the pressure
was lowered and held at the baseline pressure of 4 mm Hg. The
PBS bath was emptied, and the peripapillary sclera was treated
with 1.25% glutaraldehyde for 5 minutes as indicated in Figure
1. The sponge was then removed; excess glutaraldehyde was
washed off; the bath was refilled with fresh PBS; and three
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scans at 4, 15, and 30 mm Hg were acquired using the same
specimen.
Digital Volume Correlation. The IOP-induced deforma-
tion of the LC was computed using DVC, which is a feature-
tracking technique similar to DIC except that DVC operates on
full image volumes instead of 2D images of surfaces. We
recently characterized the application of this method to study
deformation of the porcine LC.28 Briefly, the image volumes
acquired at 15 and 30 mm Hg were correlated with the image
volume acquired at 4 mm Hg to compute the six independent
components of the spatially varying Green-Lagrange strain
tensor using the software DaVis 8.1.3 (LaVision, GmbG,
Goettingen, Germany). The subvolume size used was 20 3
203 20 voxels, with a 75% overlap, which resulted in a strain
accuracy of 20 microstrain.28 DaVis computes the correlation
value for each subvolume, which is a number between 0 and 1,
with 1 corresponding to a perfectly correlated subvolume and
0 corresponding to a subvolume that could not be correlated.
We used this value as a quality check to remove regions of the
LC that were poorly correlated, defined as subvolumes with
correlation value lower than 0.7.36 The DVC displacements
were imported into Matlab and smoothed using cubic splines
(csaps function, smoothing parameter 0.999 for all displace-
ment components). The Matlab gradient function was applied
to compute the derivatives of the displacements for the Green-
Lagrange strain formulation. The Green-Lagrange strain tensor
was then diagonalized to compute its three principal strain
components, as well as directions. Those are three mutually
perpendicular directions of pure extension or contraction.
Effects of Scleral Stiffening on the Deformation of the
LC. The effects of stiffening the peripapillary sclera on the
deformation of the LC at pressure step p were evaluated using
equation 1, where e puntreated and e
p
treated were the first principal
strains averaged over the entire LC, both computed at pressure
p. A voxel selection mask of the LC was manually created for
each of the five specimens used in this study to eliminate the
sclera, the prelaminar tissues, and postlaminar tissue from
analysis. The selection mask was created based on the
following criteria. The retina and the peripapillary sclera have
limited natural anatomic features, which resulted in those
regions being poorly correlated with DVC. Therefore, the
anterior surface of the LC and the scleral canal were easily
detectable on maps of the DVC correlation value. The density
of collagen was slightly lower in the pial septae than in the
LC.28 This caused a decrease in the correlation value at the
border between the LC and pial septa, which we used to
delineate the posterior boundary of the LC. The same mask
was used for the treated and untreated specimens. This was
possible because the masks were constructed following the
same anatomic features observed in the treated and untreated
specimens and using the value of the correlation coefficient in
the LC, which depends on tissue density and lCT parameters,
both unchanged by treatment. In addition, the specimen was
not displaced or rotated during treatment. The glutaraldehyde
was applied to the specimen while resting on the lCT stage.
Therefore, the position and orientation of the LC and its mask
were identical in the treated and untreated specimens at the
baseline pressure. In other words, the strains were averaged
over the same volume of LC tissue in the treated and untreated
specimens.
RESULTS
Diffusion of Glutaraldehyde
Overnight Incubation of LCs in Glutaraldehyde (Step
1). Fluorescence due to glutaraldehyde fixation was observed
much more strongly from tissue within the pores of the LC as
compared to the collagenous beams (Fig. 4A), likely due to the
well-known tendency of neurons to autofluoresce strongly
after aldehyde fixation.37 Since our goal was simply to
determine if there was any glutaraldehyde reaching the LC,
we focused only on the signal from the pores as the most
sensitive measure. At 550 nm, autofluorescence of the
untreated specimen was very weak (i.e., could be observed
only at a very high gain of >900), and was located primarily in
the collagen beams of the LC (Fig. 4B).
For each glutaraldehyde bath concentration, it was possible
to determine the optimal detector gain to visualize autofluo-
rescence from the LC (Fig. 4). For this optimal gain, only a few
pixels of the image were saturated (Fig. 4A, left). For each
glutaraldehyde concentration, the standard deviation of the
optimal detector gain over the LC was relatively small (Fig. 5),
suggesting that the glutaraldehyde reached a near-uniform
spatial distribution in tissue outside the LC beams after
overnight incubation. We observed three different states of
fluorescence while developing the gain–concentration curve.
At high concentrations of glutaraldehyde (>0.025%), autofluo-
rescence was observed only in the pores when the gain was set
to a level that saturated a few pixels and the concentration–
gain curve was nearly flat. At low glutaraldehyde concentra-
tions (<0.013%), the gain had to be set much higher in order to
saturate a few pixels. Here, we did not observe any signal
attributed to the glutaraldehyde in the pores; instead, we
observed mostly background fluorescence or autofluorescence
of the collagenous LC beams. At intermediate concentrations
between 0.025% (350) and 0.013% (396), the required gain
exhibited an approximately inverse linear relationship be-
tween gain and glutaraldehyde concentration. The minimum
glutaraldehyde concentration that caused measurable pore
fluorescence was between 0.013% and 0.016%.
Scleral Treatment With 1.25% Glutaraldehyde Treat-
ment (Step 2). No fluorescence was observed in the pores of
the LC after 5 and 15 minutes of scleral treatment with 1.25%
glutaraldehyde. For these short treatment times, only back-
ground fluorescence was measured in the LC (detector gain >
900 in the periphery and center of the LC), demonstrating that
FIGURE 3. Experimental protocol for PC lCT. The inflation chamber
(shown in Fig. 2) was immersed in a PBS bath, and the entire apparatus
was placed on a rotating stage. An x-ray beam, produced by
synchrotron radiation, was directed toward the ONH region. The x-
ray detector was placed 2 meters behind the specimen. For PC lCT, a
few millimeters of optic nerve were left on the eye.
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the concentration of glutaraldehyde within the LC was
uniformly lower than 0.01%. It was only after 30 minutes of
scleral treatment that we detected fluorescence in the pores at
the periphery of the LC, while at this same time point the
central region of the LC exhibited only background levels of
fluorescence. With increasing treatment time, glutaraldehyde
diffused from the scleral canal to the center of the LC (Fig. 6).
We determined the gain necessary to saturate a few pixels in
the center and periphery of the LC and used the curve shown
in Figure 5 to estimate the corresponding approximate
concentration of glutaraldehyde in those regions at different
time points. For treatment time shorter than 1.5 hours, the
amount of autofluorescence was not different than background
(gain above the threshold of 900). Autofluorescence (and
hence glutaraldehyde concentration) in the periphery rose
between 1.5 and 2.5 hours of treatment, while the center
remained at background levels of fluorescence (gain above the
threshold of 900; i.e., concentration < 0.01%) for treatment
times of up to 3.5 hours. The concentration of glutaraldehyde
in the periphery of the LC became greater than 0.03% after 2.5
hours. However, it was not possible to estimate the exact
concentration of glutaraldehyde in the periphery of the LC
because the gain–concentration curve is nearly constant for
concentrations greater than 0.03% (Fig. 5). After 6 hours of
treatment, the concentration of glutaraldehyde in the center of
the LC was estimated to be 0.020% (gain ¼ 750). In these
experiments, the specimens were washed in a PBS bath for 1
hour, which corresponded to the approximate time needed to
perform the mechanical tests. We can safely conclude that a
minimal amount of glutaraldehyde diffuses into the LC before
we finish acquiring scleral and LC deformation measurements.
Quantification of Scleral Stiffening
Glutaraldehyde treatment of the peripapillary sclera caused a
decrease in strain, as illustrated for one representative
specimen in Figures 7A and 7B. The behavior of the porcine
peripapillary sclera is nonlinear (Fig. 7C), and the relative
stiffening, calculated using equation 1, was a function of the
applied pressure (Fig. 7D).
On average, the glutaraldehyde-treated specimens exhibited
a 44% (range, 21%–61%) reduction in first principal strain at 9
mm Hg and a 22% (range, 0%–46%) reduction in first principal
strain at 38 mm Hg (Fig. 8). For all specimens, the effects of
scleral stiffening on scleral deformation were larger at lower
FIGURE 4. Confocal imaging of the LC treated with glutaraldehyde. (A) Specimen treated with glutaraldehyde for 14 hours. (B) Control specimen,
incubated in PBS for 14 hours. For both, the left column is the fluorescence signal, the center column is the transmitted light image showing the
beam/pore structure of the LC (dark/light, respectively), and the right column is the superimposition of the two signals. The fluorescence in
glutaraldehyde-treated specimens was localized to the tissue in the pores of the LC. The gain was set to 657 in (A) and to 900 in (B). At high gains
such as in (B), the beams of the LC autofluoresce. The black regions in the central images are due to pigment, commonly observed in the beams of
the porcine LC.
Effects of Scleral Stiffening on Deformation of the LC IOVS j May 2016 j Vol. 57 j No. 6 j 2671
pressures. The control specimens, left in PBS for 20 minutes,
were on average between 2% (at 38 mm Hg) and 8% (at 9 mm
Hg) more compliant in the second inflation test. However, the
average relative stiffening was statistically not different from
zero at P > 17 mm Hg (1-sample t-test with Bonferroni
correction).
Effects of Scleral Stiffening on LC Deformation
Stiffening the peripapillary sclera resulted in a decrease in the
magnitude of the three components of the principal strains in
the LC, as shown in the histograms of strains (Fig. 9), the strain
maps in a transverse PC lCT slice (Figs. 10C, 10D), and the
average strain–pressure response over the entire LC (Fig. 10B).
At 15 mm Hg, the average relative scleral stiffening was 37%
(Fig. 8, predicted from linear regression of the data shown in
that figure), which corresponded to a decrease in LC
deformation ranging from 26.5% to 58.1% (average ¼ 47%,
Fig. 11). The strain in the LC at 30 mm Hg was reduced
between 17.8% and 53.6% (average¼ 39%, Fig. 11). The results
were minimally affected when we used the 90th percentile LC
strain instead of the average LC first principal strain to evaluate
the effects of scleral stiffening on LC deformation (23.4%–
63.8% reduction at 15 mm Hg and 15.7%–61.3% reduction at
30 mm Hg).
DISCUSSION
In this study, we present experimental evidence that peripap-
illary scleral stiffening reduces biomechanical strain within the
LC. Specifically, treating the sclera with 1.25% glutaraldehyde
for 5 minutes had a direct effect on the stiffness of the sclera,
causing a 43.6 6 13.6% reduction in the maximum tensile
strain in the peripapillary sclera at low pressure (9 mm Hg) and
a 21.4 6 14.6% reduction at elevated pressure (38 mm Hg). It
also caused a decrease in LC deformation of 47.1 6 12.0% at 15
mm Hg and 39.0 6 13.5% at 30 mm Hg. We confirmed that
glutaraldehyde was confined to the sclera and minimally
diffused to the LC during the 5-minute treatment, and therefore
the strain reduction measured in the LC following scleral
stiffening was not simply due to stiffening of the LC itself.
A recent experimental study by Thornton et al.26 evaluated
the effects of glutaraldehyde treatment of the peripapillary
sclera on the deformation of the ONH. In that study, the
peripapillary sclera of porcine eyes was treated with a 4%
glutaraldehyde solution for 30 minutes using an annular
sponge, similar to our protocol. They reported an average
increase in scleral stiffness of 173% at low IOP and 67% at high
IOP (80 mm Hg), which is approximately three times the
values measured in our experiments. Differences in treatment
time and concentration most likely account for the magnitude
of the effects. In the study by Thornton et al.,26 the stiffness of
the LC was not altered by the treatment, confirming that
glutaraldehyde did not diffuse into the LC within 30 minutes.
They used a low-resolution optical method to measure strains
in the LC and reported a large decrease in tensile strain in the
LC from 10.2% to 0%, although the authors stated a lack of
confidence in the sensitivity of their method to measure small
deformations. This study extends the previous work of
Thornton et al.,26 by direct, relatively high-accuracy experi-
mental measurement of strains in the LC after scleral stiffening.
Previous finite element (FE) modeling studies also predicted
that a larger scleral stiffness would cause a decrease in LC
tensile strain when all the other parameters were held constant
(e.g., eye geometry, material properties of all other tissues).15
F o r i n s t a n c e , u s i n g t h e a p p l e t ( h t t p : / / w w w.
ocularbiomechanics.com/Software.html) created by Sigal,15
we can predict that a 40% increase in scleral modulus (from
3 to 4.2 MPa) would cause the median first principal strain in
the LC to decrease from 1.10% to 0.90% at 15 mm Hg (all other
parameters held at their default values), which corresponds to
a relative LC strain reduction of 18%. The median relative
scleral stiffening measured in our experiments at 15 mm Hg
FIGURE 5. Dose–response curve for LC fluorescence after overnight
incubation in solutions of glutaraldehyde of varying concentrations.
The vertical axis represents the microscope gain that saturated a few
pixels in the image; that is, the higher the gain, the weaker the
fluorescence. At high concentration, the gain was nearly constant,
corresponding to strong fluorescence from tissue in the pores, such as
seen in Figure 4A. At low concentration, the gain was also uniform, but
this corresponded to background fluorescence or beam autofluores-
cence such as seen in Figure 4B. In the transition zone, the gain linearly
increased with decreasing concentration, and the fluorescence was
seen in the pores.
FIGURE 6. LC fluorescence due to peripapillary scleral treatment with 1.25% glutaraldehyde. Fluorescence microscopy image of the central slice of
the LC for different durations of scleral treatment (indicated on top of each image). The parameters of the microscope were identical for all images
(tile scan 63 6 images, detector gain ¼ 700, pixel averaging ¼ 4). Because the same gain was used to generate the five images, the regions with
concentrations of glutaraldehyde larger than 0.03% are saturated. However, these images illustrate the time-dependent diffusion of glutaraldehyde
from the periphery to the center of the LC.
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(~40%) was associated with a LC strain reduction of 26.5% to
58.1%, which is slightly larger than what was predicted by the
FE models. Differences in geometry (porcine eye versus
human), material behavior (nonlinear for the porcine eye
versus linear for the human eye), or eye stiffness (LC strains in
the order of 3% to 5% for the porcine eye and 1% for the human
eye at 15 mm Hg) may account for the observed differences.
Although our findings demonstrate that stiffening the
peripapillary sclera reduces the IOP-induced mechanical
strains in the LC, it remains to be shown that scleral stiffening
is neuroprotective in glaucoma. Glaucoma is a multifactorial
disease, in which a combination of mechanical, vascular, and
biochemical events occur simultaneously. We postulate that
shielding the LC from excessive deformation will decrease the
magnitude of mechanical events such as the direct mechanical
insults to the axons or the mechanosensitive activation of
astrocytes. However, it may also have detrimental effects on
blood flow or phenotypic expression of other cell types. In
fact, a recent study by Kimball et al.22 reported increased
axonal loss in mice with induced ocular hypertension whose
sclera had been stiffened with glyceraldehyde. In that study,
the entire globe was exposed to three injections of glyceral-
dehyde, which caused an average relative scleral stiffening of
50% at 15 mm Hg and 55% at 30 mm Hg. We suggest that
constraining the treatment zone to the peripapillary sclera and
using a relatively low concentration of the stiffening solution
may decrease the magnitude of the mechanical events without
altering the vascular or biochemical response of the ONH.
Further computational modeling and animal studies controlling
the extent of the treatment zone and the magnitude of the
stiffening will be important to elucidate the neuroprotective
role of increased scleral stiffness in glaucoma.
FIGURE 7. Experiment A: Glutaraldehyde treatment of the sclera caused a pressure-dependent decrease in the magnitude of the peripapillary scleral
deformation, illustrated here for one specimen. (A) Map of the first principal strain (maximum tensile deformation) determined at 38 mm Hg before
treatment. (B) Map of the first principal strain determined at the same pressure after treatment. In (A) and (B), the two circles (r¼1.5 mm and r¼6
mm) delineate the inner and outer contours of the peripapillary scleral region where strains were averaged to estimate the relative scleral stiffening.
(C) Pressure versus averaged first principal strain before treatment (gray) and after treatment (black), quantifying the reduction in first principal
strain caused by glutaraldehyde treatment at each pressure step. The error bars represent the standard deviation of the first principal strain over the
entire peripapillary sclera region. (D) The relative scleral stiffening for this specimen was calculated using equation 1 and is plotted as a function of
the applied pressure. The calculation of the relative stiffening is illustrated at 38 mm Hg (dashed lines).
FIGURE 8. Experiment A: box plot of the relative scleral stiffening
caused by a 5-minute treatment of the peripapillary sclera with a 1.25%
glutaraldehyde solution. Scleral stiffening was calculated at five levels
of IOPs between 9 and 38 mm Hg using equation 1. The scatter plot
superimposed on each box plot represents individual specimens (n¼
14). The solid line and the dashed lines represent the average and
average 6 standard deviation of the relative stiffening calculated for six
specimens left in PBS (i.e., not subjected to glutaraldehyde treatment of
the peripapillary sclera). For those specimens, the average relative
stiffening was not different from zero at P > 17 mm Hg (adjusted P
value > 0.01). The average stiffening was always significantly different
from zero for the treated specimens (adjusted P value < 0.001).
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Several limitations should be considered when interpreting
the results of this study. The results of experiments A and B are
not directly comparable. We did not use the same eyes to
measure the effects of glutaraldehyde treatment on scleral
stiffness (experiment A) and on LC deformation (experiment
B) because the two experiments were not performed in the
same location. The age of the animals differed between the two
experiments (24 vs. 5 months old), which may have affected
the magnitude of the strains measured. Experimental studies
have shown that the sclera becomes stiffer with age.38,39 The
eyes of the young animals used for measuring LC deformation
were smaller, and it is possible that a larger proportion of the
sclera was stiffened in this experiment. This may explain why
we observed a larger strain reduction in the LC than in the
sclera. The diffusion experiments were performed using eyes
of older animals. Younger animals were smaller and probably
had a thinner sclera. Assuming that the concentration of
glutaraldehyde follows the classical unsteady diffusion equa-
tion, the concentration of delivered glutaraldehyde would be
larger in the sclera of younger eyes with thinner scleras. For
example, the same concentration would be observed in an eye
of scleral thickness T at time t as in an eye of thickness ½ T at
time ¼ t. Since we did not observe fluorescence at 20 minutes
in the older eye, we conclude that the concentration of
glutaraldehyde in the young sclera was also low at 5 minutes.
Further, the pressure loading regimens were different between
experiments A and B. In experiment A, we measured the
instantaneous response of the sclera (quasi-continuous pres-
sure increase). In experiment B, we measured the equilibrium
response of the LC as the pressure was maintained for 15
minutes before deformation measurements to prevent motion
artifacts in the scans.
Second, glutaraldehyde is cytotoxic. Other biocompatible
agents should be tested for their efficiency to cross-link scleral
collagen. We chose glutaraldehyde because it was shown to be
the most efficient and fastest chemical to stiffen the porcine
and human sclera.25 Our PC lCT method relies on access to a
synchrotron light source, which is necessarily limited by high
facility cost and demand. Fast stiffening of the sclera allowed us
to increase the number of experiments we could perform
during our time-limited visit to the Diamond Light Source. In
collagen-rich tissues such as the sclera, the mechanical
response at low pressure is dominated by the response of
the proteoglycan-rich matrix, while the crimped (wavy)
collagen fibers have a lesser contribution to the tissue stress
response. As pressure increases, collagen fibers uncrimp and
progressively carry more load, which causes the sclera to
exhibit a typical stiffening response as shown in Figure 7C. Our
findings showed that the relative stiffening was larger at low
pressures (Fig. 8), suggesting that glutaraldehyde treatment has
a greater effect on the material properties of the matrix than on
the material properties of the collagen fibers. We note that the
aqueous glutaraldehyde at room temperature could have
vaporized and cross-linked regions of the sclera or the ON
that we did not intend to cross-link.40 However, the effects
would be minimal in the LC, which is not exposed to air. We
also expect vapor fixation to have had a negligible effect on the
overall stiffness of the posterior sclera due to the short
treatment time of 5 minutes.
Digital image correlation and DVC are subject to similar
limitations in their ability to resolve small deformation, as
discussed in Coudrillier et al.28,32 The deformation in the
treated porcine peripapillary sclera varied between 1% and 3%,
and the deformation in the treated LC varied between 2% and
5%, which is at least two orders of magnitude larger than the
FIGURE 9. Experiment B: LC principal strain histograms at 15 mm Hg before and after scleral stiffening for the five specimens of this study. Strains
were computed with digital volume correlation (with respect to the reference configuration at 4 mm Hg). The vertical axis of each histogram is the
total volume of LC tissue subjected to a given strain level. Note that the y-axis scale is different between specimens, due to subject-to-subject
variations in LC size. All principal strain histograms were shifted toward zero after scleral treatment with glutaraldehyde, indicating a reduction in
deformation of the tissue of the LC after scleral stiffening.
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minimal strains DIC and DVC can resolve. Therefore, we are
confident that our strain measurements were not limited by the
resolution of DIC or DVC.
Lastly, we presented average strains over the entire LC
volume. How the regional deformation profiles were affected
by glutaraldehyde treatment was not evaluated in this study but
may be of importance. For instance, we could imagine a
scenario in which the average LC deformation was reduced by
treatment while at the same time small LC regions experienced
more deformation than the maximum deformation seen in the
untreated LC. If elevated peak strains in LC tissue drove axonal
degeneration in glaucoma, this scenario would have a
detrimental effect on vision. However, the histograms of
strains presented in Figure 9 seem to indicate that this scenario
is also unlikely. Specifically, although the shape of the
histogram was not entirely identical in the treated and
untreated specimens, the maximum first and second principal
strains over the entire LC, which are measures of the local in-
plane tensile deformation of the LC, were always lower in the
treated specimens, indicating that no region of the LC was
subjected to more stretch after treatment than the most
stretched region of the untreated LC. Similarly, the third
principal strain, a measure of the compression of the tissue,
always had lower magnitude in the treated specimens,
indicating that treatment reduced the peak compressive insult
to the LC axons and cells. This finding suggests that
peripapillary scleral stiffening decreases LC peak strains, and
therefore may be beneficial in glaucoma. It should also be
noted that we did not analyze the directions of principal
strains. We have shown in a previous paper28 that first and
second principal strain directions were largely aligned with the
in-plane direction of the posteriorly bowed LC, while the third
principal strain direction was largely parallel to the thickness
direction. How strain directions were affected by treatment
was not within the scope of this work and will be analyzed in
future studies.
FIGURE 10. Experiment B: digital volume correlation for strain calculation. (A) Transverse slice (i.e., perpendicular to the optic nerve axis) through
the PC lCT scan volume acquired at 4 mm Hg. (B) Average and standard deviation of the first, second, and third principal strains (E1, E2, and E3,
respectively) over the slice shown in (A) computed with DVC and plotted versus the applied pressure. All three principal strains were lower in the
treated specimen at both pressures. (C) Maps of the first, second, and third principal strain at 30 mm Hg in the untreated specimens. (D) Maps of
the first, second, and third principal strain at 30 mm Hg in the treated specimens. In (C) and (D), the regions outside the LC (sclera, ventral groove,
pial septa) and within the LC with a correlation value lower than 0.70 were masked and appear in black. The inferior (INF) pole is indicated in [A]).
Similar results were obtained in other transverse slices.
Effects of Scleral Stiffening on Deformation of the LC IOVS j May 2016 j Vol. 57 j No. 6 j 2675
In conclusion, we demonstrated that a moderate increase in
scleral stiffness (~10%–60%) was associated with a 25% to 76%
decrease in LC strains. Further studies should be conducted to
elucidate the neuroprotective role of scleral stiffening in
glaucoma.
Acknowledgments
The authors thank Robert Atwood, Michael Drakapoulos, Kaz
Wanelik, and Christina Reinhard from Diamond for advice on
conducting the PC lCT experiments.
Supported by Science & Technology Facilities Council Grants
EE8491, EE9825, and EE11407; the Georgia Research Alliance
(CRE); National Eye Institute Grant R01 EY025286 (CRE); and the
Department of Veterans Affairs (IK1 RX001791-01 [ICC]).
Disclosure: B. Coudrillier, None; I.C. Campbell, None; A.T.
Read, None; D.M. Geraldes, None; N.T. Vo, None; A. Feola,
None; J. Mulvihill, None; J. Albon, None; R.L. Abel, None; C.R.
Ethier, None
References
1. Quigley HA, Broman AT. The number of people with glaucoma
worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–
267.
2. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular
pressure and glaucoma progression: results from the Early
Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–
1279.
3. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma
progression and the effect of treatment: the early manifest
glaucoma trial. Arch Ophthalmol. 2003;121:48–56.
4. Noecker RJ. The management of glaucoma and intraocular
hypertension: current approaches and recent advances. Ther
Clin Risk Manag. 2006;2:193–206.
5. Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT. The
optic nerve head as a biomechanical structure: a new
paradigm for understanding the role of IOP-related stress and
strain in the pathophysiology of glaucomatous optic nerve
head damage. Prog Retin Eye Res. 2005;24:39–73.
6. Campbell IC, Coudrillier B, Ross Ethier C. Biomechanics of the
posterior eye: a critical role in health and disease. J Biomech
Eng. 2014;136:021005.
7. Anderson DR, Hendrickson A. Effect of intraocular pressure on
rapid axoplasmic transport in monkey optic nerve. Invest
Ophthalmol Vis Sci. 1974;13:771–783.
8. Sigal IA, Grimm JL, Jan NJ, Reid K, Minckler DS, Brown DJ. Eye-
specific IOP-induced displacements and deformations of
human lamina cribrosa. Invest Ophthalmol Vis Sci. 2014;55:
1–15.
9. Beckel JM, Argall AJ, Lim JC, et al. Mechanosensitive release of
adenosine 50-triphosphate through pannexin channels and
mechanosensitive upregulation of pannexin channels in optic
nerve head astrocytes: a mechanism for purinergic involve-
ment in chronic strain. Glia. 2014;62:1486–1501.
10. Rogers RS, Dharsee M, Ackloo S, Sivak JM, Flanagan JG.
Proteomics analyses of human optic nerve head astrocytes
following biomechanical strain. Mol Cell Proteomics. 2012;11:
M111.012302.
11. Girard MJ, Dupps WJ, Baskaran M, et al. Translating ocular
biomechanics into clinical practice: current state and future
prospects. Curr Eye Res. 2015;40:1–18.
12. Strouthidis NG, Girard MJ. Altering the way the optic nerve
head responds to intraocular pressure-a potential approach to
glaucoma therapy. Curr Opin Pharmacol. 2013;13:83–89.
13. Quigley HA, Cone FE. Development of diagnostic and
treatment strategies for glaucoma through understanding
and modification of scleral and lamina cribrosa connective
tissue. Cell Tissue Res. 2013;353:231–244.
14. Sigal IA, Flanagan JG, Ethier CR. Factors influencing optic
nerve head biomechanics. Invest Ophthalmol Vis Sci. 2005;
46:4189–4199.
15. Sigal IA. An applet to estimate the IOP-induced stress and
strain within the optic nerve head. Invest Ophthalmol Vis Sci.
2011;52:5497–5506.
16. Coudrillier B, Boote C, Quigley HA, Nguyen TD. Scleral
anisotropy and its effects on the mechanical response of the
optic nerve head. Biomech Model Mechanobiol. 2013;12:
941–963.
17. Nguyen C, Cone FE, Nguyen TD, et al. Studies of scleral
biomechanical behavior related to susceptibility for retinal
ganglion cell loss in experimental mouse glaucoma. Invest
Ophthalmol Vis Sci. 2013;54:1767–1780.
18. Downs JC, Suh JK, Thomas KA, Bellezza AJ, Hart RT, Burgoyne
CF. Viscoelastic material properties of the peripapillary sclera
in normal and early-glaucoma monkey eyes. Invest Ophthal-
mol Vis Sci. 2005;46:540–546.
19. Girard MJ, Suh JK, Bottlang M, Burgoyne CF, Downs JC.
Biomechanical changes in the sclera of monkey eyes exposed
to chronic IOP elevations. Invest Ophthalmol Vis Sci. 2011;52:
5656–5669.
20. Coudrillier B, Pijanka JK, Jefferys JL, et al. Glaucoma-related
changes in the mechanical properties and collagen micro-
architecture of the human sclera. PLoS One. 2015;10:
e0131396.
21. Hommer A, Fuchsjager-Mayrl G, Resch H, Vass C, Garhofer G,
Schmetterer L. Estimation of ocular rigidity based on
measurement of pulse amplitude using pneumotonometry
and fundus pulse using laser interferometry in glaucoma.
Invest Ophthalmol Vis Sci. 2008;49:4046–4050.
22. Kimball EC, Nguyen C, Steinhart MR, et al. Experimental
scleral cross-linking increases glaucoma damage in a mouse
model. Exp Eye Res. 2014;128:129–140.
23. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-
induced collagen crosslinking for the treatment of keratoco-
nus. Am J Ophthalmol. 2003;135:620–627.
24. Dotan A, Kremer I, Livnat T, Zigler A, Weinberger D, Bourla D.
Scleral cross-linking using riboflavin and ultraviolet-a radiation
for prevention of progressive myopia in a rabbit model. Exp
Eye Res. 2014;127:190–195.
FIGURE 11. Experiment B: box plot of the reduction in strain in the LC
caused by a 5-minute treatment of the peripapillary sclera with a 1.25%
glutaraldehyde solution at two levels of imposed pressures. Peripa-
pillary scleral stiffening caused a decrease in LC deformation. The
scatter plot superimposed on each box plot represents individual
specimens (n¼ 5).
Effects of Scleral Stiffening on Deformation of the LC IOVS j May 2016 j Vol. 57 j No. 6 j 2676
25. Wollensak G, Spoerl E. Collagen crosslinking of human and
porcine sclera. J Cataract Refract Surg. 2004;30:689–695.
26. Thornton IL, Dupps WJ, Roy AS, Krueger RR. Biomechanical
effects of intraocular pressure elevation on optic nerve/lamina
cribrosa before and after peripapillary scleral collagen cross-
linking. Invest Ophthalmol Vis Sci. 2009;50:1227–1233.
27. Girard M, Suh JK, Hart RT, Burgoyne CF, Downs JC. Effects of
storage time on the mechanical properties of rabbit peripap-
illary sclera after enucleation. Curr Eye Res. 2007;32:465–470.
28. Coudrillier B, Geraldes D, Vo N, et al. Phase-contrast micro-
computed tomography measurements of the intraocular
pressure-induced deformation of the porcine lamina cribrosa.
IEEE Trans Med Imaging. 2015;35:988–999.
29. Tonge TK, Murienne BJ, Coudrillier B, Alexander S, Rothkopf
W, Nguyen TD. Minimal preconditioning effects observed for
inflation tests of planar tissues. J Biomech Eng. 2013;135:
114502.
30. Collins JS, Goldsmith TH. Spectral properties of fluorescence
induced by glutaraldehyde fixation. J Histochem Cytochem.
1981;29:411–414.
31. Myers KM, Coudrillier B, Boyce BL, Nguyen TD. The inflation
response of the posterior bovine sclera. Acta Biomater. 2010;
6:4327–4335.
32. Coudrillier B, Tian J, Alexander S, Myers KM, Quigley HA,
Nguyen TD. Biomechanics of the human posterior sclera: age-
and glaucoma-related changes measured using inflation
testing. Invest Ophthalmol Vis Sci. 2012;53:1714–1728.
33. Pyne JD, Genovese K, Casaletto L, Vande Geest JP. Sequential-
digital image correlation for mapping human posterior sclera
and optic nerve head deformation. J Biomech Eng. 2014;136:
021002.
34. Atwood RC, Bodey AJ, Price SW, Basham M, Drakopoulos M. A
high-throughput system for high-quality tomographic recon-
struction of large datasets at Diamond Light Source. Philos
Trans A Math Phys Eng Sci. 2015;373:20140398.
35. Vo NT, Drakopoulos M, Atwood RC, Reinhard C. Reliable
method for calculating the center of rotation in parallel-beam
tomography. Opt Express. 2014;22:19078–19086.
36. Sukjamsri C, Geraldes DM, Gregory T, et al. Digital volume
correlation and micro-CT: an in-vitro technique for measuring
full-field interface micromotion around polyethylene implants.
J Biomech. 2015;48:3447–3454.
37. Diez-Fraile A, Van Hecke N, Gue´rin CJ, D’Herde K. Optimizing
multiple immunostaining of neural tissue. In: Dehghani H, ed.
Applications of Immunocytochemistry. InTech; 2012:345–442.
38. Coudrillier B, Pijanka J, Jefferys J, et al. Collagen structure and
mechanical properties of the human sclera: analysis for the
effects of age. J Biomech Eng. 2015;137:041006.
39. Girard MJ, Suh JK, Bottlang M, Burgoyne CF, Downs JC. Scleral
biomechanics in the aging monkey eye. Invest Ophthalmol
Vis Sci. 2009;50:5226–5237.
40. Zhang Y, Venugopal J, Huang Z-M, Lim C, Ramakrishna S.
Crosslinking of the electrospun gelatin nanofibers. Polymer.
2006;47:2911–2917.
Effects of Scleral Stiffening on Deformation of the LC IOVS j May 2016 j Vol. 57 j No. 6 j 2677
